Select Biomarkers for Tumors of the Gastrointestinal Tract: Present and Future

摘要: Context.— Advances in molecular biomarkers of the gastrointestinal tract have contributed to a decline incidence and mortality from diseases tract. The discovery clinical validation new are important personalized cancer therapy, numerous trials currently ongoing help identify individualized therapy affecting these mechanisms they represent. Distinct pathways leading cancers colorectum, esophagus, stomach, small bowel, pancreas been identified. Using direct patient care, including selection proper testing for identification actionable mutations reporting results guide clinicians genetic counselors, is paramount. Objective.— To examine review select clinically colon, pancreas, present future with relevant ...